Trial intelligence / Profile preview

Ketamine for Prevention of Chronic Post-Thoracotomy Pain

NCT00313378Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Apr 2004
Primary completion
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in neuropathic pain comparing Ketamine with Placebo (2 arms). Primary endpoint: Reduction of chronic pain on Visual Analogue Scale (VAS) at 4 months. Started Apr 2004; status: completed.

02

Drugs

ketamine
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT00313378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00313378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call